hVIVO

7 Decision Makers · 8 Verified Contacts

📍 London, England, United KingdomBiotechnology🗓 Est. 1988👥 501–1000 employees 💰 $20M–$50M

About hVIVO

hVIVO is a contract virology research company that aims to develop antivirals and vaccines in the field of biomedical research.

Leadership & Decision Makers

Contact details of 7 hVIVO decision makers

Tim Sharpington

Chief Operating Officer

Cathal Friel

Chairman and Co-Founder

Yamin 'Mo' Khan

Chief Executive Officer

Stephen Pinkerton

Chief Financial Officer

Adam French

Vice President Operations

Heather Edlund

VP Project & Data Management

Alexander Mann

Senior Director, Clinical Sciences

Team & Specialists

Contact details of 1 hVIVO team members

Rob Lambkin Williams

CSO

General Emails

General company emails, e.g. customer support lines

    info@hvivo.com

    General Inquiries

    admin@hvivo.com

    Admin Team

    feedback@hvivo.com

    General Inquiries

    legal@hvivo.com

    Legal Department

    BD@hvivo.com

    Unclassified inbox

    ir@hvivo.com

    Investor Relations

    projectadmin@hvivo.com

    Admin Team

    businessdevelopment@hvivo.com

    Unclassified inbox

    c.paterson@hvivo.com

    Unclassified inbox

    g.todd@hvivo.com

    Unclassified inbox

Similar Companies like hVIVO

GlaxoSmithKline

gsk.com
Biotechnology · London, England, United Kingdom · Est. 1929 · Above 10001 employees

HQ: London, England, United Kingdom

Tempus

tempus.com
AI & Machine Learning · Chicago, IL · Est. 2015 · 501–1000 employees · $500M–$1B

HQ: Chicago, IL

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 31/07/2025

+44 20 7756 1300

London, England, United Kingdom

Business Type: Public
Employees: 501-1000
Annual Revenue: $20M–$50M
Rounds: Series B
Founded Date: 1988
Company Type: For Profit
Stock Symbol: LSE:HVO
Operating Status: Active
Last Funding Type: Series B
Phone Number: +44 20 7756 1300
Last Investment Activity: Aug 6, 2024
Investments Activity: Aug 6, 2024 Aug 5, 2024 Aug 5, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.